Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia

INTRODUCTION: Empirical use of fluoroquinolones may delay the initiation of appropriate therapy for tuberculosis (TB). This study aimed to evaluate the impact of empirical fluoroquinolone use on the survival of patients with pulmonary TB that mimicked severe community-acquired pneumonia (CAP) requir...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Yu-Tzu, Chuang, Yu-Chung, Shu, Chin-Chung, Hung, Chien-Ching, Hsu, Chiung-Fang, Wang, Jann-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682311/
https://www.ncbi.nlm.nih.gov/pubmed/23098258
http://dx.doi.org/10.1186/cc11839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682311/
https://www.ncbi.nlm.nih.gov/pubmed/23098258
http://dx.doi.org/10.1186/cc11839

Ejemplares similares